ATE142492T1 - Felbamat zur behandlung der lennox-gastaut syndrome - Google Patents
Felbamat zur behandlung der lennox-gastaut syndromeInfo
- Publication number
- ATE142492T1 ATE142492T1 AT90313735T AT90313735T ATE142492T1 AT E142492 T1 ATE142492 T1 AT E142492T1 AT 90313735 T AT90313735 T AT 90313735T AT 90313735 T AT90313735 T AT 90313735T AT E142492 T1 ATE142492 T1 AT E142492T1
- Authority
- AT
- Austria
- Prior art keywords
- felbamat
- lennox
- treatment
- gastaut syndrome
- gastaut
- Prior art date
Links
- 201000006792 Lennox-Gastaut syndrome Diseases 0.000 title 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- WKGXYQFOCVYPAC-UHFFFAOYSA-N felbamate Chemical compound NC(=O)OCC(COC(N)=O)C1=CC=CC=C1 WKGXYQFOCVYPAC-UHFFFAOYSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Treating Waste Gases (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/412,964 US4978680A (en) | 1989-09-26 | 1989-09-26 | Method for the prevention and control of epileptic seizure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE142492T1 true ATE142492T1 (de) | 1996-09-15 |
Family
ID=23635221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90313735T ATE142492T1 (de) | 1989-09-26 | 1990-12-17 | Felbamat zur behandlung der lennox-gastaut syndrome |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4978680A (de) |
| EP (1) | EP0491094B1 (de) |
| AT (1) | ATE142492T1 (de) |
| DE (1) | DE69028542T2 (de) |
| DK (1) | DK0491094T3 (de) |
| ES (1) | ES2094145T3 (de) |
| GR (1) | GR3021801T3 (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5055489A (en) * | 1990-05-04 | 1991-10-08 | Carter-Wallace, Inc. | Method for the prevention and control of hypoxic damage resulting from cerebral ischemic events |
| DK0531105T3 (de) * | 1991-09-03 | 1997-05-12 | Carter Wallace | |
| US5290808A (en) * | 1992-11-06 | 1994-03-01 | Carter-Wallace, Inc. | Method to control the intake of food |
| US5462966A (en) * | 1993-10-15 | 1995-10-31 | Carter-Wallace Inc. | Methods for the prevention and control of cellular damage resulting from coronary artery occlusion-reperfusion |
| US5492930A (en) * | 1994-04-25 | 1996-02-20 | Schering Corporation | Method and formulation for treating CNS disorders |
| US5728728A (en) | 1996-04-10 | 1998-03-17 | Kozachuk; Walter E. | Methods of providing neuroprotection |
| US7209787B2 (en) | 1998-08-05 | 2007-04-24 | Bioneuronics Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
| US7277758B2 (en) | 1998-08-05 | 2007-10-02 | Neurovista Corporation | Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder |
| US7403820B2 (en) | 1998-08-05 | 2008-07-22 | Neurovista Corporation | Closed-loop feedback-driven neuromodulation |
| US7747325B2 (en) | 1998-08-05 | 2010-06-29 | Neurovista Corporation | Systems and methods for monitoring a patient's neurological disease state |
| US9320900B2 (en) | 1998-08-05 | 2016-04-26 | Cyberonics, Inc. | Methods and systems for determining subject-specific parameters for a neuromodulation therapy |
| US9042988B2 (en) | 1998-08-05 | 2015-05-26 | Cyberonics, Inc. | Closed-loop vagus nerve stimulation |
| US7324851B1 (en) | 1998-08-05 | 2008-01-29 | Neurovista Corporation | Closed-loop feedback-driven neuromodulation |
| US9415222B2 (en) | 1998-08-05 | 2016-08-16 | Cyberonics, Inc. | Monitoring an epilepsy disease state with a supervisory module |
| US7242984B2 (en) | 1998-08-05 | 2007-07-10 | Neurovista Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
| US7231254B2 (en) | 1998-08-05 | 2007-06-12 | Bioneuronics Corporation | Closed-loop feedback-driven neuromodulation |
| US9375573B2 (en) | 1998-08-05 | 2016-06-28 | Cyberonics, Inc. | Systems and methods for monitoring a patient's neurological disease state |
| US8762065B2 (en) | 1998-08-05 | 2014-06-24 | Cyberonics, Inc. | Closed-loop feedback-driven neuromodulation |
| DK1156798T3 (da) | 1999-02-09 | 2003-11-03 | Univ Virginia | Felbamat-afledte forbindelser |
| US20040023986A1 (en) * | 2000-10-25 | 2004-02-05 | Macdonald Timothy L. | Substituted felbamate derived compounds |
| US20030166648A1 (en) * | 2002-11-01 | 2003-09-04 | Macdonald Timothy L | Felbamate derived compounds |
| CA2606410A1 (en) * | 2005-04-21 | 2006-11-02 | Medpointe Healthcare Inc. | Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof |
| US8868172B2 (en) | 2005-12-28 | 2014-10-21 | Cyberonics, Inc. | Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders |
| US8725243B2 (en) | 2005-12-28 | 2014-05-13 | Cyberonics, Inc. | Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders |
| US20080027515A1 (en) | 2006-06-23 | 2008-01-31 | Neuro Vista Corporation A Delaware Corporation | Minimally Invasive Monitoring Systems |
| US8295934B2 (en) | 2006-11-14 | 2012-10-23 | Neurovista Corporation | Systems and methods of reducing artifact in neurological stimulation systems |
| WO2008092119A2 (en) | 2007-01-25 | 2008-07-31 | Neurovista Corporation | Systems and methods for identifying a contra-ictal condition in a subject |
| US20080183097A1 (en) * | 2007-01-25 | 2008-07-31 | Leyde Kent W | Methods and Systems for Measuring a Subject's Susceptibility to a Seizure |
| US8036736B2 (en) | 2007-03-21 | 2011-10-11 | Neuro Vista Corporation | Implantable systems and methods for identifying a contra-ictal condition in a subject |
| US9788744B2 (en) | 2007-07-27 | 2017-10-17 | Cyberonics, Inc. | Systems for monitoring brain activity and patient advisory device |
| US7884227B2 (en) * | 2007-10-26 | 2011-02-08 | Navinta Llc | Felbamate with improved bulk density |
| US20090171168A1 (en) | 2007-12-28 | 2009-07-02 | Leyde Kent W | Systems and Method for Recording Clinical Manifestations of a Seizure |
| US9259591B2 (en) | 2007-12-28 | 2016-02-16 | Cyberonics, Inc. | Housing for an implantable medical device |
| US8849390B2 (en) | 2008-12-29 | 2014-09-30 | Cyberonics, Inc. | Processing for multi-channel signals |
| US8588933B2 (en) | 2009-01-09 | 2013-11-19 | Cyberonics, Inc. | Medical lead termination sleeve for implantable medical devices |
| US8786624B2 (en) | 2009-06-02 | 2014-07-22 | Cyberonics, Inc. | Processing for multi-channel signals |
| US9643019B2 (en) | 2010-02-12 | 2017-05-09 | Cyberonics, Inc. | Neurological monitoring and alerts |
| US9233898B2 (en) | 2010-09-07 | 2016-01-12 | Taro Pharmaceutical Industries Ltd. | Process for the preparation of 2-phenyl-1,3-propanediol |
-
1989
- 1989-09-26 US US07/412,964 patent/US4978680A/en not_active Expired - Lifetime
-
1990
- 1990-12-17 DE DE69028542T patent/DE69028542T2/de not_active Expired - Lifetime
- 1990-12-17 ES ES90313735T patent/ES2094145T3/es not_active Expired - Lifetime
- 1990-12-17 AT AT90313735T patent/ATE142492T1/de not_active IP Right Cessation
- 1990-12-17 DK DK90313735.4T patent/DK0491094T3/da active
- 1990-12-17 EP EP90313735A patent/EP0491094B1/de not_active Expired - Lifetime
-
1996
- 1996-11-28 GR GR960403192T patent/GR3021801T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69028542D1 (de) | 1996-10-17 |
| ES2094145T3 (es) | 1997-01-16 |
| DE69028542T2 (de) | 1997-02-06 |
| DK0491094T3 (da) | 1996-11-11 |
| US4978680A (en) | 1990-12-18 |
| EP0491094B1 (de) | 1996-09-11 |
| EP0491094A1 (de) | 1992-06-24 |
| GR3021801T3 (en) | 1997-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE142492T1 (de) | Felbamat zur behandlung der lennox-gastaut syndrome | |
| DE69304955D1 (de) | Behandlung von neurodegenerativen Erkrankungen | |
| FI931708A0 (fi) | Herbicida substituerade aryl-haloalkylpyrazoler | |
| DE69109560D1 (de) | Fungizide Zusammensetzung zur Behandlung von Saatgut. | |
| FI875326A7 (fi) | Valonsäteilyttäjälaite korvan lääketieteelliseen hoitoon. | |
| ATE169219T1 (de) | Behandlung von katarakt mit 15-keto- prostaglandinderivaten | |
| DE3779053D1 (de) | ||
| ATE33098T1 (de) | Celiprolol zur behandlung von glaukom. | |
| DE3882642D1 (de) | Substituierte tetraline, chromane und verwandte verbindungen fuer die behandlung von asthma, arthritis und verwandte krankheiten. | |
| DE69019345D1 (de) | Zusammensetzung zur behandlung von samen. | |
| ES269846Y (es) | Disposicion de tratamiento de pestanas. | |
| DE69130586D1 (de) | Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten | |
| ES508202A0 (es) | "procedimiento de tratamiento de vegetales". | |
| ATE137116T1 (de) | Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen | |
| NO904329D0 (no) | Fremgangsmaate og katalysator for behandling av gasser sominneholder svovelforbindelser. | |
| DK0662837T3 (da) | Anvendelse af IL-10 til forhindring af insulinafhængig diabetes mellitus | |
| DE69024744D1 (de) | Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten | |
| IT8121907A0 (it) | Dispositivo per lo sterminio di lumache. | |
| NO893710D0 (no) | Fremgangsmaate for behandling av bark for havebruk. | |
| DK0430035T3 (da) | Anvendelse af benzothiazepiner til fremstilling af lægemidler til behandling af epileptiske anfald | |
| ATE6058T1 (de) | Aralkylanilinderivate und herbizide, die diese verbindungen enthalten. | |
| DK453387A (da) | Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation | |
| IT7925203A0 (it) | Procedimento per il trattamento di correnti effluenti contenenti nitrofenoli. | |
| DE69101948D1 (de) | Stabilisierungsbehandlung der katalytischen Aktivität. | |
| IT7823870A0 (it) | Impianto per il trattamento dimateriali. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEFA | Change of the company name | ||
| EELA | Cancelled due to lapse of time |